Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating IPX066 for advanced Parkinson's disease has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IPX066 (carbidopa-levodopa formulation)

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-01-14